Unprecedented patient reported improvements in chronic disease managementAmong all users of the respiratory apps 36% reduce their visits to the GP, and 19% admissions to A&E when they regularly use their app for more than six months…
In response to growing concerns about blood clots in acute COVID-19 infection and Long COVID, Professor Beverley Hunt was sought as a leading figure in blood clot management to deliver a series of tutorials. Scroll down to view the tutorials.
PROFESSOR BEVERLEY HUNT (OBE)
Consultant of Thrombosis and Haemostasis, St Thomas’ Hospital, London, and Professor of Thrombosis and Haemostasis at King’s College London
Professor Beverley Hunt is a national and international expert in thrombosis and acquired bleeding disorders,
Consultant of Thrombosis and Haemostasis, St Thomas’ Hospital, London, and Professor of Thrombosis and Haemostasis at King’s College London. Beverley sits on the NICE guideline development group, she chairs the steering committee of World Thrombosis Day campaign, and is co-founder and medical director of Thrombosis UK, a charity working to increase awareness, support research, extend understanding and improve care for all those affected by thrombosis.
Tutorials:
THE RISK OF THROMBOSIS IN LONG COVID
In this tutorial, Beverley outlines the risk of thrombosis in Long COVID, including what we know so far about thrombosis risk, seated immobility syndrome which does increase risk of blood clots, and what, if anything, does a D-dimer test tell us about someone’s risk of blood clots.
BLOOD CLOTS IN ACUTE COVID-19 INFECTION
In this tutorial, Beverley discussed blood clots in acute COVID-19 infection, including who is at risk, the types of thrombosis seen, and what preventative measures are recommended for moderately and severely unwell patients.
In this tutorial, Beverley introduces vaccine-induced immune thrombocytopenia and thrombosis syndrome, an extremely rare immune response to a vaccine causing thrombosis (blood clots) and thrombocytopenia (low platelet count), most commonly following the Astra-Zeneca vaccine.